BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11082214)

  • 1. Nitric oxide donors.
    Yamamoto T; Bing RJ
    Proc Soc Exp Biol Med; 2000 Dec; 225(3):200-6. PubMed ID: 11082214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aspirin and two nitric oxide donors on the infarcted heart in situ.
    Yamamoto T; Kakar NR; Vina ER; Johnson PE; Bing RJ
    Life Sci; 2000 Jul; 67(7):839-46. PubMed ID: 10968413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D; Currie MG; Mollace V
    J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.
    Hinz B; Schröder H
    Pharm Res; 1999 May; 16(5):633-6. PubMed ID: 10350003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of prostaglandin E2 production by the superoxide radical and nitric oxide in mouse peritoneal macrophages.
    Martinez J; Sanchez T; Moreno JJ
    Free Radic Res; 2000 Apr; 32(4):303-11. PubMed ID: 10741851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ.
    Yamamoto T; Kakar NR; Vina ER; Johnson PE; Bing RJ
    Pharmacology; 2001 Jul; 63(1):28-33. PubMed ID: 11408829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
    Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
    Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate.
    Grosser N; Schröder H
    Biochem Biophys Res Commun; 2000 Jul; 274(1):255-8. PubMed ID: 10903927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
    Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
    J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
    Govantes C; Rodríguez-Martínez MA; Marín J
    Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
    Chirkov YY; De Sciscio M; Sverdlov AL; Leslie S; Sage PR; Horowitz JD
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):131-7. PubMed ID: 20490904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries.
    Wellman TL; Jenkins J; Penar PL; Tranmer B; Zahr R; Lounsbury KM
    FASEB J; 2004 Feb; 18(2):379-81. PubMed ID: 14657004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide inhibits prostanoid synthesis in the rat oviduct.
    Perez Martinez S; Farina M; Ogando D; Ribeiro ML; Gimeno M; Franchi AM
    Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):239-42. PubMed ID: 10882188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of nitric oxide donor compounds in the bactericidal activity of human neutrophils in vitro.
    Klink M; Cedzyński M; St Świerzko A; Tchórzewski H; Sulowska Z
    J Med Microbiol; 2003 Apr; 52(Pt 4):303-308. PubMed ID: 12676868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of reactive nitrogen intermediates on prostaglandin E2 synthesis in cultured rat microglia and RAW 264.7 cells.
    Guastadisegni C; Minghetti L; Nicolini A; Polazzi E; Balduzzi M; Levi G
    Adv Exp Med Biol; 1999; 469():169-74. PubMed ID: 10667327
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a Korean traditional formulation, Hwaotang, on superoxide generation in human neutrophils, platelet aggregation in human blood, and nitric oxide, prostaglandin E2 production and paw oedema induced by carrageenan in mice.
    Park WH; Park SY; Kim HM; Kim CH
    Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):53-73. PubMed ID: 15106732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.
    Muzaffar S; Shukla N; Angelini G; Jeremy JY
    Circulation; 2004 Aug; 110(9):1140-7. PubMed ID: 15326075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of nitric oxide donors and ascorbic acid on D-[3H] aspartate efflux from rat striatal slices.
    Reiser M; Schild L; Keilhoff G; Wolf G
    Neurochem Res; 1999 Jan; 24(1):61-7. PubMed ID: 9973238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation.
    Paolocci N; Ekelund UE; Isoda T; Ozaki M; Vandegaer K; Georgakopoulos D; Harrison RW; Kass DA; Hare JM
    Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1982-8. PubMed ID: 11009488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.